Journal of Cell Communication and Signaling

, Volume 10, Issue 3, pp 229–240 | Cite as

CCN family of proteins: critical modulators of the tumor cell microenvironment

Review
First Online:
Received:
Accepted:

Abstract

The CCN family of proteins consisting of CCN1 (Cyr61), CCN2 (CTGF), CCN3 (NOV), CCN4 (WISP-1), CCN5 (WISP-2) and CCN6 (WISP-3) are considered matricellular proteins operating essentially in the extracellular microenvironment between cells. Evidence has also been gradually building since their first discovery of additional intracellular roles although the major activity is triggered at the cell membrane. The proteins consist of 4 motifs, a signal peptide (for secretion} followed consecutively by the IGFBP, VWC, TSP1 and CT (C-terminal cysteine knot domain) motifs, which signify their potential binding partners and functional connections to a variety of key regulators of physiological processes. With respect to cancer it is now clear that, whereas certain members can facilitate tumor behavior and progression, others can competitively counter the process. It is therefore clear that the net outcome of biological interactions in the matrix and what gets signaled or inhibited can be a function of the interplay of these CCN 1–6 proteins. Because the CCN proteins further interact with other key proteins, like growth factors in the matrix, the balance is not only important but can vary dynamically with the physiological states of tumor cells and the surrounding normal cells. The tumor niche with its many cell players has surfaced as a critical determinant of tumor behavior, invasiveness, and metastasis. It is in this context that CCN proteins should be investigated with the potential of being recognized and validated for future therapeutic approaches.

Keywords

CCN proteins Cancer 
This is a preview of subscription content, log in to check access.

References

  1. Aguiar DP, de Farias GC, de Sousa EB, de Mattos Coelho-Aguiar J, Lobo JC, Casado PL, Duarte ME, Abreu JG Jr (2014) New strategy to control cell migration and metastasis regulated by CCN2/CTGF. Cancer Cell Int 14:61CrossRefPubMedPubMedCentralGoogle Scholar
  2. Akalay I, Tan TZ, Kumar P, Janji B, Mami-Chouaib F, Charpy C, Vielh P, Larsen AK, Thiery JP, Sabbah M, Chouaib S (2015) Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression. Oncogene 34:2261–2271Google Scholar
  3. Banerjee SK, Banerjee S (2012) CCN5/WISP-2: a micromanager of breast cancer progression. J Cell Commun Signal 6:63–71CrossRefPubMedPubMedCentralGoogle Scholar
  4. Bartel F, Balschun K, Gradhand E, Strauss HG, Dittmer J, Hauptmann S (2012) Inverse expression of cystein-rich 61 (Cyr61/CCN1) and connective tissue growth factor (CTGF/CCN2) in borderline tumors and carcinomas of the ovary. Int J Gynecol Pathol 31:405–415CrossRefPubMedGoogle Scholar
  5. Benini S, Perbal B, Zambelli D, Colombo MP, Manara MC, Serra M, Parenza M, Martinez V, Picci P, Scotlandi K (2005) In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type. Oncogene 24:4349–4361CrossRefPubMedGoogle Scholar
  6. Bhavani GS, Shah H, Dalal AB, Shukla A, Danda S, Aggarwal S, Phadke SR, Gupta N, Kabra M, Gowrishankar K, Gupta A, Bhat M, Puri RD, Bijarnia-Mahay S, Nampoothiri S, Mohanasundaram KM, Rajeswari S, Kulkarni AM, Kulkarni ML, Ranganath P, Ramadevi AR, Hariharan SV, Girisha KM (2015) Novel and Recurrent mutations in WISP3 and an atypical phenotype. Am J Med Genet Part A 167 A:2481–2484CrossRefGoogle Scholar
  7. Bleau AM, Planque, Perbal B (2005) CCN proteins and cancer: two to tango. Front Biosci 10:998–1009CrossRefPubMedGoogle Scholar
  8. Chang C-C, Yang M-H, Lin B-R, Chen S-T, Pan S-H, Hsiao M, Lai T-C, Lin S-K, Jeng Y-M, Chu C-Y, Chen R-H, Yang P-C, Chin YE, Kuo M-L (2013) CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation. Cell Death Differ 20:443–455CrossRefPubMedGoogle Scholar
  9. Chang C-C, Lin B-R, T-S W, Jeng Y-M, Kuo M-L (2014) Input of microenvironmental regulation on colorectal cancer: role of the CCN family. World J Gastroenterol 20:6826–6831CrossRefPubMedPubMedCentralGoogle Scholar
  10. Chang C-H, T-T O, Yang M-Y, Huang C-C, Wang C-J (2016) Nelumbo nucifera Gaertn leaves extract inhibits the angiogenesis and metastasis of breast cancer cells by downregulation connective tissue growth factor (CTGF) mediated PI3K/AKT/ERK signaling. J Ethnopharmacol 188:111–122CrossRefPubMedGoogle Scholar
  11. Chen P-C, Lin T-H, Cheng H-C, Tang C-H (2012) CCN3 increases cell motility and ICAM-1 expression in prostate cancer cells. Carcinogenesis 33:937–945CrossRefPubMedGoogle Scholar
  12. Chen J, Gao Y, Xu B, Cui X, Xu D (2014a) NOV is upregulated and promotes migration and invasion in bladder cancer. Tumor Biol 35:6749–6755CrossRefGoogle Scholar
  13. Chen J, Yin J, Li X, Wang Y, Zheng Y, Qian C, Xiao L, Zou T, Wang Z, Liu J, Zhang W, Zhou H, Liu Z (2014b) WISP1 polymorphisms contribute to platinum-based chemotherapy toxicity in lung cancer patients. Int J Mol Sci 15:21011–21027CrossRefPubMedPubMedCentralGoogle Scholar
  14. Chen L, Charrier A, Zhou Y, Chen R, Yu B, Agarwal K, Tsukamoto H, Lee LJ, Paulaitis ME, Brigstock DR (2014c) Epigenetic regulation of connective tissue growth factor by microRNA-214 delivery in exosomes from mouse or human hepatic stellate cells. Hepatology 59:1118–1129CrossRefPubMedPubMedCentralGoogle Scholar
  15. Chen J, Yin J-Y, Li X-P, Wang Y, Zheng Y, Qian C-Y, Fang C, Wang Z, Zhang Y, Xiao L, Wang S-Y, Zhang W, Zhou H-H, Liu Z-Q (2015) Association of Wnt-Inducible signaling pathway protein 1 genetic polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response. Clin Lung Cancer 16:298–304CrossRefPubMedGoogle Scholar
  16. Chiang K-C, Yeh C-N, Chung L-C, Feng T-H, Sun C-C, Chen M-F, Jan Y-Y, Yeh T-S, Chen S-C, Juang H-H (2015) WNT-1 inducible signaling pathway protein-1 enhances growth and tumorigenesis in human breast cancer. Sci Rept 5:8686CrossRefGoogle Scholar
  17. Chintalapudi MR, Markiewicz M, Kose N, Dammai V, Champion KJ, Hoda RS, Trojanowska M, Hsu T (2008) Cyr61/CCN1 and CTGF/CCN2 mediate the proangiogenic activity of VHL-mutant renal carcinoma cells. Carcinogenesis 29:696–703CrossRefPubMedPubMedCentralGoogle Scholar
  18. Chong HC, Tan CK, Huang R-L, Tan NS (2012) Matricellular proteins: a sticky affair with cancers. J Oncol 2012:351089CrossRefPubMedPubMedCentralGoogle Scholar
  19. Chuang J-Y, Chen P-C, Tsao C-W, Chang A-C, Lein M-Y, Lin C-C, Wang S-W, Lin C-W, Tang C-H (2015) WISP-1, a novel angiogenic regulator of the CCN family, promotes oral squamous cell carcinoma angiogenesis through VEGF-A expression. Oncotarget 6:4239–4252CrossRefPubMedPubMedCentralGoogle Scholar
  20. Cicha I, Goppelt-Struebe M (2009) Connective tissue growth factor: context-dependent functions and mechanisms of regulation. Biofactors 35:200–208CrossRefPubMedGoogle Scholar
  21. Cui L, Xie R, Dang S, Zhang Q, Mao S, Chen J, Qu J, Zhang J (2014) NOV promoted the growth and migration of pancreatic cancer cells. Tumor Biol 35:3195–3201CrossRefGoogle Scholar
  22. Emre Y, Imhof BA (2014) Matricellular protein CCN1/CYR61: a new player in inflammation and leukocyte trafficking. Semin Immunopathol 36:253–259CrossRefPubMedGoogle Scholar
  23. Fang F, Zhao W-Y, Li R-K, Yang X-M, Li J, Ao J-P, Jiang S-H, Kong F-Z, Tu L, Zhuang C, Qin W-X, He P, Zhang W-M, Cao H, Zhang Z-G (2014) Silencing of WISP3 suppresses gastric cancer cell proliferation and metastasis and inhibits Wnt/β-catenin signaling. Int J Clin Exp Pathol 7:6447–6461PubMedPubMedCentralGoogle Scholar
  24. Ferrand N, Gnanapragasam A, Dorothee G, Redeuilh G, Larsen AK, Sabbah M (2014) Loss of WISP2/CCN5 in estrogen-dependent MCF7 human breast cancer cells promotes a stem-like cell phenotype. PLoS One 9: e87878Google Scholar
  25. Frewer KA, Sanders AJ, Owen S, Frewer NC, Hargest R, Jiang G (2013) A role for WISP2 in colorectal cancer cell invasion and motility. Cancer Genomics Proteomics 10:187–196PubMedGoogle Scholar
  26. Gellhaus A, Dong X, Propson S, Maass K, Klein-Hitpass L, Kibschull M, Traub O, Willecke K, Perbal B, Lye SJ, Winterhager E (2004) Connexin43 interacts with NOV: a possible mechanism for negative regulation of cell growth in choriocarcinoma cells. J Biol Chem 279:36931–36942CrossRefPubMedGoogle Scholar
  27. Gilkes DM, Semeza GL, Wirtz D (2014) Hypoxia and the extracellular matrix: drivers of tumour metastases. Nat Rev Cancer 14:430–439Google Scholar
  28. Glukhova L, Angevin E, Lavialle C, Cadot B, Terrier-Lacombe MJ, Perbal B, Bernheim A, Goguel AF (2001) Patterns of specific genomic alterations associated with poor prognosis in high-grade renal cell carcinomas. Cancer Genet Cytogenet 130:105–110CrossRefPubMedGoogle Scholar
  29. Gonzalez-Guerrico AM, Espinoza I, Schroeder B, Park CH, Mohan KVPC, Khurana A, Corominas-Faja B, Cuyàs E, Alarcón T, Kleer C, Menendez JA, Lupu R (2016) Suppression of endogenous lipogenesis induces reversion of the malignant phenotype and normalized differentiation in breast cancer. Oncotarget 7:1–18Google Scholar
  30. Gupta N, Wang H, McLeod TL, Naus CC, Kyurkchiev S, Advani S, Yu J, Perbal B, Weichselbaum RR (2001) Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV). Mol Pathol 54:293–299CrossRefPubMedPubMedCentralGoogle Scholar
  31. Gurbuza I, Chiquet-Ehrismann R (2015) CCN4/WISP1 (WNT1 inducible signaling pathway protein 1): a focus on its role in cancer. Int J Biochem Cell Biol 62:142–146CrossRefGoogle Scholar
  32. Haque I, De A, Majumder M, Mehta S, McGregor D, Banerjee SK, Van Veldhuizen P, Banerjee S (2012) The matricellular protein CCN1/Cyr61 is a critical regulator of sonic hedgehog in pancreatic carcinogenesis. J Biol Chem 287:38569–38579CrossRefPubMedPubMedCentralGoogle Scholar
  33. Hara, C, Kubota, S, Nishida, T, Hiasa, M, Hattori, T, Aoyama, E ,Moriyama, Y, Kamioka, H, Takigawa, M (2016) Involvement of multiple CCN family members in platelets that support regeneration of joint tissues. Mod Rheumatol 21:1–10Google Scholar
  34. Holbourn KP, Acharya KR, Perbal B (2008) The CCN family of proteins: structure–function relationships. Trends Biochem Sci 33:461–473CrossRefPubMedPubMedCentralGoogle Scholar
  35. Huang Y-T, Lan Q, Ponsonnet L, Blanquet M, Christofori G, Zaric J, Rüegg C (2016a) The matricellular protein CYR61 interferes with normal pancreatic islets architecture and promotes pancreatic neuroendocrine tumor progression. Oncotarget 7:1663–1674PubMedGoogle Scholar
  36. Huang W, Martin EE, Burman B, Gonzalez ME, Kleer CG (2016b) The matricellular protein ccn6 (WISP3) decreases notch1 and suppresses breast cancer initiating cells. Oncotarget 7:25180–25193PubMedGoogle Scholar
  37. Hutchenreuther J, Vincent KM, Carter DE, Postovit LM, Leask A (2015) CCN2 expression by tumor stroma is required for melanoma metastasis. J Invest Dermatol 135:2805–2813CrossRefPubMedGoogle Scholar
  38. Ishida J, Kurozumi K, Ichikawa T, Otani Y, Onishi M, Fujii K, Shimazu Y, Oka T, Shimizu T, Date I (2015) Evaluation of extracellular matrix protein CCN1 as a prognostic factor for glioblastoma. Brain Tumor Pathol 32:245–252CrossRefPubMedGoogle Scholar
  39. Jandova J, Beyer TE, Meuillet EJ, Watts GS (2012) The matrix protein CCN1/CYR61 is required for αVβ5-mediated cancer cell migration. Cell Biochem Funct 30:687–695CrossRefPubMedPubMedCentralGoogle Scholar
  40. Jeong D, Heo S, Ahn TS, Lee S, Park S, Kim H, Park D, Bae SB, Lee SS, Lee MS, Kim C-J, Baek MJ (2014) Cyr61 expression is associated with prognosis in patients with colorectal cancer. BMC Cancer 14:164CrossRefPubMedPubMedCentralGoogle Scholar
  41. Ji, J, Jia, S, Ji, K, Jiang, WG (2014) Wnt1 inducible signaling pathway protein-2 (WISP-2/CCN5): roles and regulation in human cancers (Review). Oncol Rept 31:533–539Google Scholar
  42. Ji J, Jia S, Jia Y, Ji K, Hargest R, Jiang WG (2015) WISP-2 in human gastric cancer and its potential metastatic suppressor role in gastric cancer cells mediated by JNK and PLC-c pathways. Brit. J Cancer 113:921–933CrossRefGoogle Scholar
  43. Jia Q, Dong Q, Qin L (2016) CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma? Oncotarget 7:1203–1214PubMedGoogle Scholar
  44. Kawaki H, Kubota S, Suzuki A, Lazar N, Yamada T, Matsumura T, Ohgawara T, Maeda T, Perbal B, Lyons KM, Takigawa M (2008) Cooperative regulation of chondrocyte differentiation by CCN2 and CCN3 shown by a comprehensive analysis of the CCN family proteins in cartilage. J Bone Miner Res 23:1751–1764CrossRefPubMedGoogle Scholar
  45. Kikuchi R, Tsuda H, Kanai Y, Kasamatsu T, Sengoku K, Hirohashi S, Inazawa J, Imoto I (2007) Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer. Cancer Res 67:7095–7105CrossRefPubMedGoogle Scholar
  46. Kim GJ, Rhee H, Yoo JE, Ko JE, Lee JS, Kim H, Choi JS, Park YN (2014) Increased expression of CCN2, epithelial membrane antigen, and fibroblast activating factor in hepatocellular carcinoma with fibrous stroma showing aggressive behavior. PLoS One 9:e105094CrossRefPubMedPubMedCentralGoogle Scholar
  47. Klinke DJ II (2014) Induction of wnt-inducible signaling protein-1 correlates with invasive breast cancer oncogenesis and reduced type 1 cell-mediated cytotoxic immunity: a retrospective study. PLoS Comput Biol 10:e1003409CrossRefPubMedGoogle Scholar
  48. Krupska I, Bruford EA, Chaqour B (2015) Eyeing the Cyr61/CTGF/NOV (CCN) group of genes in development and diseases: highlights of their structural likenesses and functional dissimilarities. Hum Genomics 9:24Google Scholar
  49. Kubota S, Takigawa M (2015) Cellular and molecular actions of CCN2/CTGF and its role under physiological and pathological conditions. Clin Sci 128:181–196CrossRefPubMedGoogle Scholar
  50. Lacle MM, van Diest PJ, Goldschmeding R, van der Wall E, Nguyen TQ (2015) Expression of connective tissue growth factor in male breast cancer: clinicopathologic correlations and prognostic value. PLoS One 10:e0118957CrossRefPubMedPubMedCentralGoogle Scholar
  51. Lau LF (2011) CCN1/CYR61: the very model of a modern matricellular protein. Cell Mol Life Sci 68:3149–3163CrossRefPubMedPubMedCentralGoogle Scholar
  52. Lau LF (2016) Cell surface receptors for CCN proteins. J Cell Commun Signal 10:121–127CrossRefPubMedPubMedCentralGoogle Scholar
  53. Leal LF, Mermejo LM, Ramalho LZ, Martinelli CE Jr, Yunes JA, Seidinger AL, Mastellaro MJ, Cardinalli IA, Brandalise SR, Moreira AC, Tone LG, Scrideli CA, Castro M, Antonini SR (2011) Wnt/β-catenin pathway deregulation in childhood adrenocortical tumors. J Clin Endocrinol Metab 96:3106–3114CrossRefPubMedGoogle Scholar
  54. Lecot P, Alimirah F, Desprez P-Y, Campisi J, Wiley C (2016) Context-dependent effects of cellular senescence in cancer development. Br J Cancer 114:1180–1184CrossRefPubMedPubMedCentralGoogle Scholar
  55. Li W-F, Zhang L, Li H-Y, Zheng S-S, Zhao L (2014) WISP-1 contributes to fractionated irradiation-induced radioresistance in esophageal carcinoma cell lines and mice. PLoS One 9:e94751CrossRefPubMedPubMedCentralGoogle Scholar
  56. Li J, Ye L, Owen S, Weeks HP, Zhang Z, Jiang WG (2015) Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review). Int J Mol Med 36:1451–1463PubMedPubMedCentralGoogle Scholar
  57. Lin C-C, Chen P-C, Lein M-Y, Tsao C-W, Huang C-C, Wang S-W, Tang C-H, Tung K-C (2016) WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells. Oncotarget 7:1993–10005Google Scholar
  58. Liu S-C, Lee H-P, Hung C-Y, Tsai C-H, Li T-M, Tang C-H (2015) Berberine attenuates CCN2-induced IL-1β expression and prevents cartilage degradation in a rat model of osteoarthritis. Toxicol Appl Pharmacol 289:20–29CrossRefPubMedGoogle Scholar
  59. Long Q-Z, Zhou M, Liu X-G, Y-F D, Fan J-H, Lia X, He D-L (2013) Interaction of CCN1 with αvβ3 integrin induces P-glycoprotein and confers vinblastine resistance in renal cell carcinoma cells. Anti-Cancer Drugs 24:810–817CrossRefPubMedGoogle Scholar
  60. Lorenzatti G, Huang W, Pal A, Cabanillas AM, Kleer CG (2011) CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancer. J Cell Sci 124:1752–1758CrossRefPubMedPubMedCentralGoogle Scholar
  61. Maillard M, Cadot B, Ball RY, Sethia K, Edwards DR, Perbal B, Tatoud R (2001) Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues. Mol Pathol 54:275–280CrossRefPubMedPubMedCentralGoogle Scholar
  62. Malta DFB, Reticker-Flynn NE, da Silva CL, Cabral JMS, Fleming HE, Zaret KS, Bhatia SN, Underhill GH (2016) Extracellular matrix microarrays to study inductive signaling for endoderm specification. Acta Biomater 34:30–40CrossRefGoogle Scholar
  63. Manara MC, Perbal B, Benini S, Strammiello R, Cerisano V, Perdichizzi S, Serra M, Astolfi A, Bertoni F, Alami J, Yeger H, Picci P, Scotlandi K (2002) The expression of ccn3(nov) gene in musculoskeletal tumors. Am J Pathol 160:849–859CrossRefPubMedPubMedCentralGoogle Scholar
  64. McCallum L, Price S, Planque N, Perbal B, Pierce A, Whetton AD, Irvine AE (2006) A novel mechanism for BCR-ABL action: stimulated secretion of CCN3 is involved in growth and differentiation regulation. Blood 108:1716–1723CrossRefPubMedGoogle Scholar
  65. McCallum L, Lu W, Price S, Lazar N, Perbal B, Irvine AE (2009) CCN3: a key growth regulator in chronic myeloid leukaemia. J Cell Commun Signal 3:115–124CrossRefPubMedPubMedCentralGoogle Scholar
  66. Meng X-M, Nikolic-Paterson DJ, Lan HY (2016) TGF-β: the master regulator of fibrosis. Nat Rev Nephrol 12:325–338CrossRefPubMedGoogle Scholar
  67. Morales MG, Gutierrez J, Cabello-Verrugio C, Cabrera D, Lipson KE, Goldschmeding R, Brandan E (2013) Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy. Hum Mol Genet 22:4938–4951CrossRefPubMedGoogle Scholar
  68. Murphy-Ullrich JE, Sage EH (2014) Revisiting the matricellular concept. Matrix Biol 37:1–14CrossRefPubMedPubMedCentralGoogle Scholar
  69. Nieto, MA, Huang, RY-J, Jackson, RA, Thiery, JP (2016) EMT: 2016. Cell 166: 21–45.Google Scholar
  70. Ono M, Inkson CA, Sonn R, Kilts TM, de Castro LF, Maeda A, Fisher LW, Robey PG, Berendsen AD, Li L, McCartney-Francis N, Brown AC, Crawford NPS, Molinolo A, Jain A, Fedarko NS, Young MF (2013) WISP1/CCN4: A Potential Target for inhibiting prostate cancer growth and spread to bone. PLoS ONE 8(8):e71709CrossRefPubMedPubMedCentralGoogle Scholar
  71. Pal A, Huang W, Li X, Toy KA, Nikolovska-Coleska Z, Kleer CG (2012a) CCN6 modulates BMP signaling via the smad-independent TAK1/p38 pathway, acting to suppress metastasis of breast cancer. Cancer Res 72:4818–4828CrossRefPubMedPubMedCentralGoogle Scholar
  72. Pal A, Huang W, Toy KA, Kleer CG (2012b) CCN6 knockdown disrupts acinar organization of breast cells in three-dimensional cultures through upregulation of type II TGF-β receptor. Neoplasia 14:1067–1074CrossRefPubMedPubMedCentralGoogle Scholar
  73. Patel P, Brooks C, Seneviratne A, Hess DA, Seguin CA (2014) Investigating microenvironmental regulation of human chordoma cell behavior. PLoS ONE 9:e115909CrossRefPubMedPubMedCentralGoogle Scholar
  74. Patraa, M, Mahatab, SK, Padhana, DK, Sena, M (2016) CCN6 (Wnt induced signaling protein – 3) regulates mitochondrial function. Cell Sci Advanced June 1, 2016Google Scholar
  75. Pennica D, Swanson TA, Welsh JW, Roy MA, Lawrence DA, Lee J, Brush J, Taneyhill LA, Deuel B, Lew M, Watanabe C, Cohen RL, Melhem MF, Finley GG, Quirke P, Goddard AD, Hillan KJ, Gurney AL, Botstein D, Levine AJ (1998) WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci U S A 95:14717–14722CrossRefPubMedPubMedCentralGoogle Scholar
  76. Perbal B (1999) Nuclear localisation of NOVH protein: a potential role for NOV in the regulation of gene expression. Mol Pathol 52:84–91CrossRefPubMedPubMedCentralGoogle Scholar
  77. Perbal B (2001) NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol Pathol 54:57–79CrossRefPubMedPubMedCentralGoogle Scholar
  79. Perbal B (2013) CCN proteins: a centralized communication network. J Cell Commun Signal 7:169–177CrossRefPubMedPubMedCentralGoogle Scholar
  80. Perbal B, Zuntini M, Zambelli D, Serra M, Sciandra M, Cantiani L, Lucarelli E, Picci P, Scotlandi K (2008) Prognostic value of CCN3 in osteosarcoma. Clin Cancer Res 14:701–709CrossRefPubMedGoogle Scholar
  81. Perbal B, Lau L, Lyons K, Kubota S, Yeger H, Fisher G (2016) Report on the 8th international workshop on the CCN family of genes – Nice November 3–8, 2015. J Cell Commun Signal 10:77–86CrossRefPubMedPubMedCentralGoogle Scholar
  82. Piszczatowski RT, Lents NH (2016) Regulation of the CCN genes by vitamin D: a possible adjuvant therapy in the treatment of cancer and fibrosis. Cell Signal 28:1604–1613. Google Scholar
  83. Rachfal AW, Luquette MH, Brigstock DR (2004) Expression of connective tissue growth factor (CCN2) in desmoplastic small round cell tumour. J Clin Pathol 57:422–425CrossRefPubMedPubMedCentralGoogle Scholar
  84. Rayego-Mateos S, Rodrigues-Diez R, Morgado-Pascual JL, Rodrigues Diez RR, Mas S, Lavoz C, Alique M, Pato J, Keri G, Ortiz A, Egido J, Ruiz-Ortega M (2013) Connective tissue growth factor is a new ligand of epidermal growth factor receptor. J Mol Cell Biol 5:323–335CrossRefPubMedGoogle Scholar
  85. Riser BL, Najmabadi F, Perbal B, Peterson DR, Rambow JA, Riser ML, Sukowski E, Yeger H, Riser SC (2009) CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease. Am J Pathol 174:1725–1734CrossRefPubMedPubMedCentralGoogle Scholar
  86. Rodrigues-Diez RR, Garcia-Redondo AB, Orejudo M, Rodrigues-Diez R, Briones AM, Bosch-Panadero E, Kery G, Pato J, Ortiz A, Salaices M, Egido J, Ruiz-Ortega M (2015) The C-terminal module IV of connective tissue growth factor, through EGFR/Nox1 signaling, activates the NF-kB pathway and proinflammatory factors in vascular smooth muscle cells. Antioxid Redox Signal 22:29–48CrossRefPubMedPubMedCentralGoogle Scholar
  87. Russo JW, Castellot JJ Jr (2010) CCN5: biology and pathophysiology. J Cell Commun Signal 4:119–130CrossRefPubMedPubMedCentralGoogle Scholar
  88. Saglam O, Dai F, Husain S, Zhan Y, Toruner G, Haines IIIGK (2014) Matricellular protein CCN1 (CYR61) expression is associated with high-grade ductal carcinoma in situ. Hum Pathol 45:1269–1275CrossRefPubMedGoogle Scholar
  89. Schlegelmilch K, Keller A, Zehe V, Hondke S, Schilling T, Jakob F, Klein-Hitpass L, Schütze N (2014) WISP 1 is an important survival factor in human mesenchymal stromal cells. Gene 551:243–254CrossRefPubMedGoogle Scholar
  90. Shiga K, Hara M, Nagasaki T, Sato T, Takahashi H, Takeyama H (2015) Cancer –associated fibroblasts: their characteristics and their roles in tumor growth. Cancers (Basel) 7:2443–2458CrossRefGoogle Scholar
  91. Suresh S, McCallum L, Crawford LJ, WH L, Sharpe DJ, Irvine AE (2013) The matricellular protein CCN3 regulates NOTCH1 signalling in chronic myeloid leukaemia. J Pathol 231:378–387CrossRefPubMedPubMedCentralGoogle Scholar
  92. Tai H-C, Chang A-C, H-J Y, Huang C-Y, Tsai Y-C, Lai Y-W, Sun H-L, Tang C-H, Wang S-W (2014) Osteoblast-derived WISP-1 increases VCAM-1 expression and enhances prostate cancer metastasis by down-regulating miR-126. Oncotarget 5:7589–7598CrossRefPubMedPubMedCentralGoogle Scholar
  93. Tsai H-C, Huang C-Y, Su H-L, Tang C-H (2014) CCN2 enhances resistance to cisplatin-mediating cell apoptosis in human osteosarcoma. PLoS One 9: e90159Google Scholar
  94. Ueda M, Iguchi T, Komatsu H, Kidogami S, Hu Q, Sato K, Ogawa J, Nambara S, Saito T, Sakimura S, Hirata H, Uchi R, Shinden Y, Eguchi H, Ito S, Masuda T, Yamamoto H, Doki Y, Mori M, Mimori K (2015) Clinical significance of expression of nephroblastoma overexpressed (NOV) in patients with colorectal cancer. Anticancer Res 35:6591–6598PubMedGoogle Scholar
  95. Vallacchi V, Daniotti M, Ratti F, Di Stasi D, Deho P, De Filippo A, Tragni G, Balsari A, Carbone A, Rivoltini L, Parmiani G, Lazar N, Perbal B, Rodolfo M (2008) CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma. Cancer Res 68:715–723CrossRefPubMedGoogle Scholar
  96. Wagener J, Yang W, Kazuschke K, Winterhager E, Gellhaus A (2013) CCN3 regulates proliferation and migration properties in Jeg3 trophoblast cells via ERK1/2, Akt and Notch signaling. Mol Hum Reproduct 19:237–249CrossRefGoogle Scholar
  97. Wallace DM, Clark AF, Lipson KE, Andrews D, Crean JK, O’Brien CJ (2013) Anti-connective tissue growth factor antibody treatment reduces extracellular matrix production in trabecular meshwork and lamina cribrosa cells. Invest Ophthalmol Vis Sci 54:7836–7848CrossRefPubMedGoogle Scholar
  98. Wells JE, Howlett M, Cole CH, Kees UR (2015a) Deregulated expression of connective tissue growth factor (CTGF/CCN2) is linked to poor outcome in human cancer. Int. J. Cancer 137:504–511CrossRefPubMedGoogle Scholar
  99. Wells JE, Howlett M, Cheung LC, Kees UR (2015b) The role of CCN family genes in haematological malignancies. J Cell Commun Signal 9:267–278CrossRefPubMedPubMedCentralGoogle Scholar
  100. Wu L, Runkle C, Jin H-J, Yu J, Li J, Yang X, Kuzel T, Lee C, Yu J (2014) CCN3/NOV gene expression in human prostate cancer is directly suppressed by the androgen receptor. Oncogene 33:504–513CrossRefPubMedGoogle Scholar
  101. Xu H, Li P, Liu M, Liu C, Sun Z, Guo X, Zhang Y (2015) CCN2 and CCN5 exerts opposing effect on fibroblast proliferation and transdifferentiation induced by TGF-β. Clin Exp Pharmacol Physiol 42:1207–1219CrossRefPubMedGoogle Scholar
  102. Yang Z, Yang Z, Zou Q, Yuan Y, Li J, Li D, Liang L, Zeng G, Chen S (2014) A comparative study of clinicopathological significance, FGFBP1, and WISP-2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder. Int J Clin Oncol 19:325–335CrossRefPubMedGoogle Scholar
  103. Yao J, Weng Y, Yan S, Hou M, Wang H, Shi Q, Zuo G (2015) NOV inhibits proliferation while promoting apoptosis and migration in osteosarcoma cell lines through p38/MAPK and JNK/.MAPK pathways. Oncol Rept 34:2011–2023Google Scholar
  104. Yeger H, Perbal B (2007) The CCN family of genes: a perspective on CCN biology and therapeutic potential. J Cell Commun Signal 1:159–164CrossRefPubMedGoogle Scholar
  105. Zeng J, Liao Y, Zhou J, Yang G, Ding K, Zhang X (2015) Role of WISP3 siRNA in proliferation, apoptosis and invasion of bladder cancer cells. Int J Clin Exp Med 8:12792–12800PubMedPubMedCentralGoogle Scholar
  106. Zhang H, Luo H, Hu Z, Peng J, Jiang Z, Song T, Wu B, Yue J, Zhou R, Xie R, Chen T, Wu S (2015a) Targeting WISP1 to sensitize esophageal squamous cell carcinoma to irradiation. Oncotarget 6:6218–6234CrossRefPubMedPubMedCentralGoogle Scholar
  107. Zhang H, Li W, Huang P, Lin L, Ye H, Lin D, Koeffler HP, Wang J, Yin D (2015b) Expression of CCN family members correlates with the clinical features of hepatocellular carcinoma. Oncol Rept 33:1481–1492Google Scholar

Copyright information

© The International CCN Society 2016

Authors and Affiliations

  1. 1.Program in Developmental & Stem Cell Biology, Research InstituteThe Hospital for Sick ChildrenTorontoCanada
  2. 2.CNRS, GREDEG, International CCN SocietyUniversité Côte d’AzurCôte d’AzurFrance

Personalised recommendations